APPLICATION
ANDA209085
TYPE
ANDA
ORIGINAL APPROVAL
2022-05-25
LATEST ACTION
2024-02-29
ROUTE
INTRAVENOUS
DOSAGE FORM
POWDER
MARKETING STATUS
Discontinued
Products
PEMETREXED DISODIUMDiscontinued
PEMETREXED DISODIUM EQ 1GM BASE/VIAL · POWDER · INTRAVENOUS
Approval history
2024-02-29Labeling · Supplement 1 · standardAP
2024-02-29Labeling · Supplement 2 · standardAP
2024-02-29Labeling · Supplement 3 · standardAP
2022-05-25UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.